Back to MORGAN STANLEY MORGAN STANLEY

TCRXTCRX
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in TSCAN THERAPEUTICS INC

MORGAN STANLEY holds 197,891 shares of TCRX (TSCAN THERAPEUTICS INC), worth $193,952 as of 2026-Q2. The position was increased (+14.0% shares).

Current Value

$193,952

Current Shares

197,891

Total Value Change

-$1.3M

Total Shares Change

-101,428

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
197,891
+14.0%
$193,9520.0%$0.98
18
2026-Q1
Decreased
173,643
-23.1%
$175,3790.0%$1.03
0
2025-Q4
Decreased
225,829
-73.3%
$225,8290.0%$1.03
0
2025-Q3
Decreased
847,537
-0.7%
$1.5M0.0%$1.74
0
2025-Q2
Increased
853,346
+43.9%
$1.2M0.0%$1.40
34
2025-Q1
Increased
592,970
+43.6%
$818,2980.0%$1.35
33
2024-Q4
Increased
412,858
+37.9%
$1.3M0.0%$3.00
33
2024-Q3
Increased
299,319
+23.9%
$1.5M0.0%$5.04
31

Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used